IONpath Appoints Brad Nelson to Its Leadership Team as Senior VP of Marketing and Corporate Strategy

1 256

IONpath, Inc. the leader in multiplexed spatial tissue imaging and analysis, announced the appointment of Brad Nelson to the position of Senior Vice President of Marketing and Corporate Strategy. Mr. Nelson will lead marketing, product management and application functions to meet the increasing demand for translational medicine insights that can only be achieved with Multiplexed Ion Beam Imaging (MIBI™).

Rapid growth in immuno-oncology and adjacent markets requires approaches that can sensitively detect and quantify the expression of multiple biomarkers while preserving spatial information. IONpath is uniquely capable of addressing these market needs and is positioned for rapid commercial growth both with their MIBIScope™ instrument and their comprehensive Research Services offering. Mr. Nelson will provide commercial leadership as IONpath meets this increasing demand from pharma, biotech and academic customers.

Marketing Technology News: Kibo’s AI-Based Personalization Drives 80% Conversion Rate Increase for Room & Board

“Brad brings a unique combination of broad marketing and corporate development experience and a deep technical background,” Dr. Harris Fienberg, IONpath CEO said. “Our entire team is excited to have Brad on board to guide our immuno-oncology strategy and expand our offerings into new markets.”

Mr. Nelson has over twenty years of experience in leading rapid growth life science and medical device organizations. He has a track record of success at early stage companies bringing new technology and applications to market, driving rapid growth from product inception to broad scale adoption. Most recently he served as Vice President of Marketing at Magnolia Medical Technologies leading the brand and product portfolio development for the company’s Steripath technology which experienced rapid adoption and over 70 percent annual revenue growth.

Marketing Technology News: Pointillist Cited as a Leader in Journey Orchestration Platforms by Independent Research Firm

Prior to Magnolia Medical, Mr. Nelson served as Head of Marketing and Director of Corporate Development at Labcyte Inc., leading the development of new global markets and collaborations that delivered sustained revenue growth and the acquisition by Danaher Corporation. Previously he led the marketing organization at Velocity11 Inc., building a highly differentiated brand and robotics product portfolio that led to industry leading growth and the acquisition by Agilent Technologies.

“I am thrilled to join the world class team at IONpath,” Nelson said. “IONpath has the rare combination of groundbreaking technology backed by a team of scientists and engineers that can turn data into insights. Working closely with our pharmaceutical, biotech and academic partners we will deliver on the promise of precision medicine for oncology, immunology, neuroscience and infectious disease markets enabling new discoveries that improve patient care.”

Marketing Technology News: The Association of State and Territorial Health Officials Chooses Qualtrics CoreXM

1 Comment
  1. […] IONpath Appoints Brad Nelson to Its Leadership Team as Senior VP of Marketing and Corporate Strategy  MarTech Series […]

Leave A Reply

Your email address will not be published.